{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/123-US9,535,057(active).pdf"}, "page_content": "Some biological questions of cardiac electrophysiology can\n\nmodel to screen agents for cardiotoxic effect, particularly\n\nnot simply be addressed by in vitro assays. In this case, in\n\nalteration in heart rate and in heart beat rhythm. Teleosts,\n\n60\n\nVivo models have been applied, including Guinea pig, dog,\n\neither embryos or larvae, are bathed in medium containing\n\ntesting agents for a particular period of time. Then, the\n\nand primate. ECG is continuously recorded over a range of\n\nteleost is immobilized by agarose, agar or methyl-cellulose.\n\nincreasing doses in anaesthetized animal to detect the occur\n\nrence of any cardiac arrhythmia. Moreover, they are not\n\nCirculation of blood cells are videoed under microscope\n\nequipped with digital camera connected to a recording\n\nwidely used due to the ethical issues and cost efficiency.\n\n65\n\nTherefore, there is a need to develop a new technology with\n\ndevice, such as a VCR recorder, digital video camera or\n\nlower cost and higher efficiency.\n\npersonal computer. Video of blood circulation is then ana\n\nUS 9,535,057 B2\n\n2\n\n1\n\nMETHOD OF IN VIVO SCREENING FOR CARDIAC TOXIC AGENTS USING TELEOST", "type": "Document"}}